The human circadian timing system evolved while our ancestors spent most of their days outside in bright daylight and their nights in the dark from sunset to sunrise ([@bibr22-0748730420923164]). Today, in industrialized societies, less than 8% of time is spent outdoors and more than 87% indoors ([@bibr18-0748730420923164]), where humans are exposed to thousand-fold dimmed light during the day (e.g., 100 lux indoors versus up to 100,000 lux outdoors) and thousand-fold brightening during the night (e.g., 100 lux or more indoors versus \<0.1 lux outside in the pre-electric world).

Insufficient light during the day and excessive light exposure during evening and night hours disrupts the human circadian timing system and may cause impaired sleep, immunity, and mood, and it is associated with increased risks of obesity and diabetes as well as breast, prostate, and other neuroendocrine-sensitive cancers ([@bibr2-0748730420923164]; [@bibr27-0748730420923164]; [@bibr36-0748730420923164]). In 2010, the World Health Organization International Agency for Research on Cancer classified nightshift work with circadian disruption as a probable (group 2A) human carcinogen ([@bibr17-0748730420923164]), and in 2018, the US National Toxicology Program expert panel concluded that circadian disruption caused by excessive light at night and insufficient light during the day is reasonably anticipated to be a human carcinogen ([@bibr38-0748730420923164]). Yet, our modern 24/7 society depends on the use of electric lighting at night and lowered indoor illumination levels during the day.

A potential spectral engineering solution to this problem was raised by the discovery that the circadian timing system primarily responds to short-wavelength visible light ([@bibr37-0748730420923164]; [@bibr3-0748730420923164]), mediated by several subtypes of intrinsically photosensitive retinal ganglion cells (ipRGCs) containing the photopigment melanopsin (Opn4; [@bibr1-0748730420923164]), some of which also receive rod- and cone-initiated photoresponses ([@bibr23-0748730420923164]). The ipRGCs and ON bipolar cells presynaptic to the ipRGCs can remain continuously active when exposed to blue light ([@bibr40-0748730420923164]). The M1 and M2 subtypes of ipRGCs transmit the day-night pattern of retinal illuminance via a retinohypothamic tract directly to neurons in the circadian pacemaker in the suprachiasmatic nucleus (SCN) of the hypothalamus ([@bibr10-0748730420923164]). In turn, the SCN communicates circadian temporal information to ensure internal synchronization of the multioscillator circadian timing system via neuroendocrine pathways including the timing of melatonin release from the pineal gland, which, when measured as saliva or plasma melatonin, serves as a useful indicator of the timing of the circadian system ([@bibr28-0748730420923164]).

The spectral sensitivity of the circadian timing system across the visible light spectral range (380-780 nm) has previously been assessed using short monochromatic light exposures in dark-adapted human subjects with pharmacologically dilated pupils. [@bibr37-0748730420923164] blindfolded subjects for 0.5 to 3.5 h and [@bibr3-0748730420923164], [@bibr4-0748730420923164]) blindfolded them for 2 h prior to exposure to monochromatic lights of different visible wavelengths for 30 min and 90 min, respectively, during late evening hours. In vitro studies using short monochromatic light exposures of small pieces of human retinae ([@bibr23-0748730420923164]) and of human melanopsin expressed in human embryonic kidney cells (HEK-293; [@bibr1-0748730420923164]) have also been used to define circadian spectral sensitivity. The circadian spectral sensitivity curves derived from these in vivo and in vitro studies span a broad band of 400 to 429 nm (hereinafter referred to as violet), 430 to 499 nm (hereinafter blue), and 500 to 560 nm (hereinafter green) wavelengths, but their reported peak sensitivities (λ~max~ 457-479 nm) are distinct from the spectral sensitivity curves of rod (λ~max~ 498 nm) and S-cone (λ~max~ 420 nm), M-cone (λ~max~ 534 nm) and L-cone (λ~max~ 564 nm) pigments ([@bibr3-0748730420923164]; [@bibr23-0748730420923164]).

However, there are important differences between the short ≤90-min exposures of dark-adapted retinae to monochromatic lights previously used to derive the circadian spectral sensitivity curve and the typical light-adapted human exposure to natural and/or electric polychromatic white light for up to \~16 continuous hours.

Several lines of evidence suggest that the circadian spectral sensitivity under normal light-adapted working conditions may have a narrower wavelength distribution than that defined by the previous studies. When human subjects are illuminated by polychromatic white light for 12 h at night at workplace levels of light intensity (600-1000 lux table top), [@bibr31-0748730420923164] and [@bibr11-0748730420923164] have reported near complete restoration of melatonin levels when \<500-nm dichroic cutoff filters are used to eliminate violet and blue, but not green, wavelengths. Similarly, when [@bibr13-0748730420923164] exposed previously dark-adapted human subjects to extended 6-h exposures of either monochromatic green (555 nm) or blue (460 nm) lights, both green and blue light had similar suppressive effects on melatonin over the first 30 min, but green light--induced melatonin suppression rapidly decayed over the next 2 h, whereas blue light maintained a sustained suppression of melatonin throughout the 6-h exposure. [@bibr13-0748730420923164] suggested that transitory extrinsic input to ipRGCs from M-cones may account for the sensitivity to green wavelengths for the first 1 to 2 h after dark adaptation, but under normal extended polychromatic light exposures, these green wavelengths (500-575 nm) do not contribute significantly to the light-adapted circadian spectral sensitivity curve.

A similar phenomenon may occur from transitory extrinsic input to ipRGCs from S-cones (λ~max~ 420 nm), with violet light exposure. A comparison of melatonin suppression with different durations of monochromatic violet (420-424 nm) light exposure in subjects who have been dark adapted by wearing blindfolds in a dark room revealed that 30 min of violet light exposure produced 95% melatonin suppression ([@bibr37-0748730420923164]) whereas 90 min of violet light exposure produced only 27% of maximum melatonin suppression ([@bibr4-0748730420923164]). Furthermore, [@bibr35-0748730420923164] found that a 3-h light exposure with peak emission at 420 nm caused minimal melatonin suppression.

The reduced circadian sensitivity to violet and green wavelengths with extended light exposures suggests that the circadian spectral sensitivity curve under a normal duration (8-16 h) polychromatic white light exposure in light-adapted subjects may have a narrower spectral range than previously reported.

To test this hypothesis, we measured the circadian spectral sensitivity using (1) a light exposure time of 12 h instead of brief ≤90-min light exposures; (2) a comparison of 6 different polychromatic overhead ceiling white light-emitting diode (LED) light sources with diverse spectral power distributions to probe circadian spectral sensitivity, instead of the monochromatic light stimuli previously used; (3) exposures to illumination levels recommended by the IES Lighting Handbook for health care and manufacturing work surfaces (540 lux = 50 foot candles, horizontally at table top; [@bibr8-0748730420923164]), providing 254 to 323 lux vertical illuminance at the cornea of the eye; and (4) measurements of the total 12-h nocturnal (2000-0800 h) suppression of melatonin (area under the curve) as a circadian disruption biomarker ([@bibr20-0748730420923164]) that has direct relevance to health outcomes ([@bibr15-0748730420923164]).

Materials and Methods {#section1-0748730420923164}
=====================

Human Subject Selection {#section2-0748730420923164}
-----------------------

Adult human subjects were recruited through local advertisements and screened to ensure they had regular sleep patterns with nocturnal sleep from 2300 h to 0700 h (±1 h), were nonsmokers, and were medication free. Enrollment exclusion criteria included recent history of shift work, recent travel history across time zones, history of sleep disorders, color blindness (as determined by the Ishihara Test for Color Blindness; [@bibr25-0748730420923164]), history of ocular/vision disorders, depression as measured on the Center for Epidemiological Studies ([@bibr29-0748730420923164]) and other self-reported medical or psychiatric illnesses as screened by a general health questionnaire.

Thirty-four subjects (26 men, 8 women) aged 18 to 41 years (mean age 28 years) were enrolled in the study. Each participant gave written informed consent after receiving a full explanation of the study purpose, design, and procedures. The study protocol and consent forms were reviewed and approved by the Circadian Institutional Review Board (IRB 00001522) registered for federal wide assurance with the Office for Human Research Protections of the Department of Health and Human Services.

Research Protocol and Data Collection {#section3-0748730420923164}
-------------------------------------

For 7 days prior to each overnight study, all participants were instructed to maintain a preset sleep schedule (2300 h to 0700 h ± 30 min) and to maintain sleep diaries, which were confirmed with actigraphy. On the day of the study, the individual subjects awoke at their habitual time at home, pursued their normal daytime activities, and arrived at the Circadian Light Research Center at 1800 h for the overnight study session. All simulated night shifts were conducted with the subjects seated around a conference room table in a light-controlled workplace simulation area of the research center, illuminated by overhead lighting at a ceiling height of 8 feet.

During each simulated night shift condition (2000 h to 0800 h), groups of 8 to 13 subjects were continuously illuminated by 1 of the 6 polychromatic white LED light sources with the spectral power distributions labelled A-F in [Figure 1](#fig1-0748730420923164){ref-type="fig"} (top), and reported in 1-nm increments between 360 nm and 760 nm in [Supplementary Table S1](https://journals.sagepub.com/doi/suppl/10.1177/0748730420923164), each adjusted to provide 50-foot candles (540 lux) of horizontal table-top polychromatic white illuminance at the level of the conference room table around which the subjects were seated. Table-top and corneal eye-level spectral irradiance (spectrophotometer at a seated eye level directed toward the wall, 17 inches above and parallel to the table) was measured, and the total and photopigment-weighted (α-opic) irradiance values for each light source as well as total photon irradiance and photopic lux were calculated with the CIE S026:2018 Toolbox (March 2019 S026 testing version issued to tutorial participants; [@bibr5-0748730420923164]). [Table 1](#table1-0748730420923164){ref-type="table"} shows the total visible (380-760 nm) irradiance, illuminance, log photon irradiance, and photopigment-weighted illuminance values for each LED light source (A-F) using the eye-level vertical irradiance measurements. In addition, we exposed subjects to 1 fluorescent light source, with the spectral power distribution shown in [Figure 1](#fig1-0748730420923164){ref-type="fig"} and illuminance and irradiance values shown in [Table 1](#table1-0748730420923164){ref-type="table"}, under the same experimental protocol and conditions.

![Spectral power distributions of polychromatic white light sources and resulting curves of overnight salivary melatonin levels. (Top) Normalized spectral power distributions of 6 polychromatic white light-emitting diode light sources (A-F) and 1 fluorescent light source (Fluor) measured at the cornea (eye level) of human subjects seated around a conference table illuminated at 540 lux table top. (Bottom) Salivary melatonin levels in pg/mL (mean ± SEM) measured overnight (2000 h to 0800 h) from subjects under each light source (A-F and Fluor).](10.1177_0748730420923164-fig1){#fig1-0748730420923164}

###### 

Characteristics of the eye-level (corneal) illumination delivered by the 6 light-emitting diode light sources (A, B, C, D, E, F) and the fluorescent light all adjusted to provide 540 lux (50-foot candles) of table-top horizontal illumination.

![](10.1177_0748730420923164-table1)

  Light Source   Light Characteristics (Unweighted)   Photopigment-Weighted (α-Opic) Irradiances (µW/cm^2^)                                            
  -------------- ------------------------------------ ------------------------------------------------------- -------- ------- ------- ------- ------- -------
  LED A          105.01                               300.69                                                  14.477   17.47   39.85   48.48   32.74   27.19
  LED B          78.27                                254.25                                                  14.360   7.77    29.90   41.74   19.70   15.09
  LED C          114.96                               253.82                                                  14.492   10.77   30.25   41.32   19.36   14.04
  LED D          83.81                                269.34                                                  14.394   7.19    31.37   44.29   20.25   15.43
  LED E          113.09                               320.67                                                  14.507   8.77    36.81   52.86   22.91   16.55
  LED F          108.41                               322.60                                                  14.495   7.25    36.44   52.82   21.03   14.08
  Fluor          85.06                                304.77                                                  14.380   10.64   38.23   49.26   27.65   21.64

The overnight shift work simulation, when the subjects were not being tested, consisted of playing board games, with one of the research investigators in the room at all times making sure that all subjects kept continuously awake with their eyes open. Subjects were instructed to remain seated (with eyes about 17 inches above the table), to look straight ahead with the direction of gaze parallel to the table surface as much as possible during their activities, and to avoid looking directly into the ceiling lights at all times while in the simulation test room. They wore \<500-nm cutoff dichroic blue-filtering glasses ([@bibr31-0748730420923164]) during brief bathroom breaks, which were not allowed during the 20 min prior to each testing time (lighting in hallway and bathroom was dimmed). From arrival at the facility to entering the night-shift simulation area at 2000 h, subjects were seated under standard fluorescent office light at approximately 540 lux table top. They were provided dinner at 1900 h and then 3 isocaloric meals every 4 h (after saliva sampling at 2300 h, 0300 h, and 0700 h). Water was the only beverage allowed during the simulation nights and available ad libitum, except for the 20 min prior to each saliva sampling time. Subjects were instructed to refrain from caffeinated beverages after breakfast and to not consume alcohol on the day prior to each simulated night shift.

Salivary melatonin samples were collected using the Salivette method (Sarstedt AG & Co, Nürmbrecht Germany), at set intervals of 30 or 60 min during each simulated night shift between 2000 h and 0800 h and immediately frozen. The samples were assayed for melatonin by SolidPhase Inc (Portland, ME) using the Bühlmann Direct Saliva Melatonin Radioimmunoassay (Bühlmann Diagnostics, Amherst, NH), which has a functional sensitivity of 0.9 pg/mL and an analytical sensitivity of 0.2 pg/mL, an intra-assay precision of 2.6% to 20.1% coefficient of variation (CV), and an interassay precision of 6.6% to 16.7% CV. The mean and standard error of the mean salivary melatonin results in pg/mL collected under each light source are shown in [Supplemental Table S2](https://journals.sagepub.com/doi/suppl/10.1177/0748730420923164).

Data Analysis {#section4-0748730420923164}
-------------

The area under the curve (AUC) of melatonin levels during the nocturnal rise and fall of melatonin concentration between 2000 h and 0800 h was calculated for each individual subject night, using the trapezoid method ([@bibr26-0748730420923164]). The trapezoid AUC method used the normalized units h∙pg/mL, taking into account the exact time interval between 2 consecutive data points (i.e., 30 min or 60 min) and allowing comparability of the data regardless of sampling interval. The mean ± SEM melatonin AUC was determined for each lighting condition, as shown in [Supplemental Table S2](https://journals.sagepub.com/doi/suppl/10.1177/0748730420923164).

A data analyst (R.G.) who was unacquainted with, and blind to, previously published circadian spectral sensitivity curves was asked to independently derive the best curve fit between the melatonin AUC data and the relative spectral power distribution of each of the 6 LED light sources. Because our goal was to maintain the photopic illuminance levels required for adequate visual acuity while minimizing circadian disruption, we used as the optimization parameter the ratio between the total relative Circadian Potency spectral sensitivity based on total melatonin AUC suppression and the total relative photopic power^380-760^ (circadian potency/phototopic ratio \[CPPR\]). The photopic function with a peak at 555 nm and a full width at half maximum (FWHM) of 100 nm between 510 and 610 nm describes the brightness of light perceived by the human eye based on the properties of the visual cones in the retina ([@bibr5-0748730420923164]). For each of the 6 LED light sources, the normalized spectral power distribution between 380 and 760 nm was multiplied by the photopic power at each wavelength to calculate the total relative photopic power between 380 and 760 nm (total relative photopic power^380-760^).

Rather than using a simple Gaussian curve fit, we allowed for negatively and positively skewed solutions by independently optimizing 3 parameters: (1) peak Circadian Potency spectral sensitivity wavelength (µ) and 2 separate Gaussian functions ( $\mathbf{P}\left( \lambda \right) = \frac{1}{\sigma*\left. \sqrt{}2\pi \right.}*\mathbf{e}^{- \ \frac{{({\lambda - \mu})}^{2}}{2\sigma^{2}}}$, where *P* = relative circadian potency, λ = wavelength, µ = peak Circadian Potency wavelength, σ = standard deviation, σ2 = variance) for (2) wavelengths less than µ, and (3) wavelengths greater than µ. The final asymmetric curve was assembled using the values from the short-wavelength Gaussian curve for λ ≤ µ and using the values from the long-wavelength Gaussian curve for λ \> µ. Before assembling, the optimized the best-fit Circadian Potency curves for both sides of the peak Circadian Potency wavelength value were scaled so that the maximum relative Circadian Potency µ was equal to 1.0.

Results {#section5-0748730420923164}
=======

[Figure 1](#fig1-0748730420923164){ref-type="fig"} (bottom) shows the mean and SEM melatonin curves measured overnight from 2000 h to 0800 h under the 6 LED light sources (A-F) and 1 fluorescent light source (Fluor) with the spectral power distributions shown in [Figure 1](#fig1-0748730420923164){ref-type="fig"} (top). We found a greater than 5-fold variation in the mean nocturnal melatonin AUC between the different LED light sources at the same light intensity. The melatonin AUC ranged between 11.2 and 64.3 h∙pg/mL depending on the spectral power distribution of the white light source, even though each light source was maintained at the same 540 lux table-top light intensity continuously during the 12-h test session.

The CPPR ranged from 0.11 to 0.33 for the 6 tested LED light sources. Analysis of variance calculations indicated a statistical difference in the AUC values among the LED light conditions (Kruskal-Wallis one-way analysis of variance on ranks: *P* = 0.02). [Figure 2](#fig2-0748730420923164){ref-type="fig"} (top) shows the optimized best-fit regression function between CPPR and melatonin AUC, which had an *R*^2^ coefficient of 0.991. [Figure 2](#fig2-0748730420923164){ref-type="fig"} (bottom) displays the optimized Circadian Potency spectral sensitivity curve ($P\left( \lambda \right))$function, which provided the best-fit melatonin AUC versus CPPR linear regression line shown in [Figure 2](#fig2-0748730420923164){ref-type="fig"} (top). For wavelengths shorter than the 477-nm peak Circadian Potency spectral sensitivity wavelength, the optimized curve fit was $\mathbf{P}\left( \lambda \right) = \frac{1}{33.8*\left. \sqrt{}2\pi \right.}*\mathbf{e}^{- \frac{{({\lambda - 477.0})}^{2}}{2*{33.8}^{2}}}$, and for wavelengths longer than the 477-nm peak, it was $\mathbf{P}\left( \lambda \right) = \frac{1}{13.8*\sqrt{2\pi}}*\mathbf{e}^{- \frac{{({\lambda - 477.0})}^{2}}{2*{13.8}^{2}}}$.

![Derivation of optimized spectral sensitivity of normalized Circadian Potency for 12-h exposure to polychromatic white light-emitting diode (LED) light. (Top) Optimized linear regression fit between the circadian potency/photopic ratio (CPPR) of each LED light source and mean ± SEM melatonin total area under the curve. The result from the fluorescent light source (Fluor) is also shown. (Bottom) Optimized Circadian Potency spectral sensitivity curve that provided the best linear regression fit in Figure 2 (top), with 76% of spectral sensitivity falling in the full-width half maximum 438- to 493-nm blue band depicted with the color of 477 nm blue.](10.1177_0748730420923164-fig2){#fig2-0748730420923164}

The Circadian Potency spectral sensitivity curve had a right width at half maximum of 16 nm and a left width at half maximum of 39 nm. Thus, the Circadian Potency curve had an FWHM of 55 nm from 438 nm to 493 nm that was negatively skewed. Seventy-six percent of the total Circadian Potency spectrally sensitive irradiant power fell within the 438- to 493-nm FWHM band.

To characterize the transient behavior of circadian spectral sensitivity, we compared the steady-state Circadian Potency spectral sensitivity curve derived from this study (with 12-h light exposures) with the best-fit curves for the published experimentally derived data for 30-min light exposures ([@bibr37-0748730420923164]) and for 90-min light exposures ([@bibr3-0748730420923164]; [@bibr4-0748730420923164]) obtained using the same 3-parameter optimized curve-fitting methodology ([Fig. 3](#fig3-0748730420923164){ref-type="fig"}). As light exposure is extended, there is a progressive transition of the circadian spectral sensitivity curve. The decay of the S-cone violet and M-cone green transient spectral responses to light appears to be associated with a progressive right shift of the maximum circadian sensitivity from 430 nm (30-min exposure) to 440 nm (90-min exposure) to 477 nm (720-min exposure) and a progressive narrowing of the circadian sensitivity curve from an FWHM of more than 100 nm (30-min exposure) to 85 nm (90-min exposure) to 55 nm (720-min exposure).

![Comparison of normalized circadian spectral sensitivity curves of 30-min, 90-min, and 12-h light exposures. Raw data from [@bibr37-0748730420923164] for 30-min (•) and [@bibr3-0748730420923164], [@bibr4-0748730420923164]) for 90-min (▲) light exposures plus their best-fit asymmetric Gaussian functions. After violet and green transient decay, the residual steady-state Circadian Potency spectral sensitivity curve is narrower, right shifted, and negatively skewed.](10.1177_0748730420923164-fig3){#fig3-0748730420923164}

Because all light sources were adjusted to provide the same horizontal table-top level of illumination (the standard measure that lighting designers use to illuminate indoor spaces), and because the spectral power distributions of the chosen LED light sources were significantly diverse, the intensity of total visible light entering the eye (measured vertically at eye level with the subjects seated at the conference table) varied between the light sources. This provided the opportunity to determine if the melatonin AUC was influenced by corneal light metrics (irradiance in µW/cm^2^, photon irradiance in photons/cm^2^/s, photopic illuminance in lux). Individual pupil sizes and macular pigment optical density were not measured and were not taken into account. As [Figure 4](#fig4-0748730420923164){ref-type="fig"} (left) shows, there was no significant correlation between light intensity by any of these metrics and the melatonin AUC results.

![Relationships between melatonin area under the curve and corneal total visible irradiance (top left), corneal photon irradiance (middle left), corneal illuminance in lux (bottom left), circadian stimulus (CS; top right), CIE melanopic irradiance (**middle left**), and circadian potency/photopic ratio (bottom left).](10.1177_0748730420923164-fig4){#fig4-0748730420923164}

We next examined how well the most commonly used circadian lighting calculators, the circadian stimulus (CS; [@bibr32-0748730420923164]), CIE melanopic irradiance ([@bibr5-0748730420923164]), and the closely related equivalent melanopic lux (EML) calculator ([@bibr19-0748730420923164]), correlated with the 12-h overnight melatonin AUC data measured in light-adapted human subjects under the 6 polychromatic white LED light sources. [Figure 4](#fig4-0748730420923164){ref-type="fig"} (right) compares the *R*^2^ coefficient of determination for melatonin AUC for (top) CS (*R*^2^ = 0.001), (middle) melanopic irradiance (*R*^2^ = 0.690), and (bottom) CPPR (*R*^2^ = 0.991). The CS, CIE, and also EML calculators derived primarily by using short monochromatic light exposures of dark-adapted retinae did not predict the 12-h overnight melatonin AUC results as accurately as the Circadian Potency spectral sensitivity curve reported here.

The one fluorescent light source we tested under this experimental protocol with the spectral power distribution shown in [Supplementary Table S1](https://journals.sagepub.com/doi/suppl/10.1177/0748730420923164) was calculated to have a CPPR value of 0.276 and a projected melatonin AUC of 28 h∙pg/mL using our LED light--derived Circadian Potency spectral sensitivity curve. The 12-h exposure to the fluorescent light at 540 lux resulted in a melatonin AUC of 37.0 ± 13.4 h∙pg/mL ([Fig. 2A](#fig2-0748730420923164){ref-type="fig"}), and thus, the CPPR-predicted melatonin AUC of 28 h∙pg/mL fell within the measured SEM.

Discussion {#section6-0748730420923164}
==========

In contrast to the previously reported circadian spectral sensitivity curves derived using short exposures of dark-adapted retinae to monochromatic lights, the Circadian Potency spectral sensitivity curve derived in this study with extended 12-h exposures to polychromatic white LED lights in light-adapted subjects had a peak at 477 nm and a narrower spectral range of circadian active predominantly blue wavelengths (FWHM 438-493 nm) with substantially less contributions from violet (400-429 nm) and green (500-560 nm) wavelengths. This finding is consistent with the hypothesis of [@bibr13-0748730420923164] that the initial circadian system sensitivity to green wavelengths in dark-adapted subjects is most likely the consequence of transitory extrinsic input to ipRGCs from M-cones (λ~max~ = 534 nm and potentially rods with λ~max~ = 498 nm). Similarly, it would appear that the initial sensitivity to violet wavelengths in dark-adapted subjects may be a result of transitory extrinsic input to ipRGCs from S-cones (λ~max~ = 420nm), which dissipates with extended violet (400-429 nm) light exposure.

The Circadian Potency spectral sensitivity for extended polychromatic light exposures that is largely confined to blue wavelengths explains the near complete restoration of melatonin levels in humans ([@bibr31-0748730420923164]; [@bibr11-0748730420923164]) and attenuation of circadian phase resetting in rats ([@bibr12-0748730420923164]) when \<500-nm dichroic cutoff filters are used to eliminate violet and blue, but not green, wavelengths in extended 12-h exposures to polychromatic white light. Similarly, the narrow Circadian Potency spectral sensitivity explains the findings of [@bibr35-0748730420923164] of melatonin restoration in violet-enriched blue-depleted light. Furthermore, it explains how a 12-µW/cm^2^ monochromatic 480-nm blue light source near the peak of the Circadian Potency spectral sensitivity curve with pharmacologically dilated eyes could produce a comparable-amplitude circadian phase-response curve as a 3000-µW/cm^2^ polychromatic white light source ([@bibr34-0748730420923164]).

The peak Circadian Potency wavelength (λ~max~ = 477 nm) found in this study of light-adapted human subjects under extended 12-h exposures to polychromatic light is close to the peak sensitivity (λ~max~ \~ 479 nm) of human melanopsin in vitro ([@bibr1-0748730420923164]), supporting an intrinsic ipRGC melanopsin-mediated sustained circadian response. However, the spectral sensitivity curve determined by exposing human melanopsin expressed in human embryonic kidney cells (HEK-293) to monochromatic light flashes and measuring the dynamics of the first minute of intracellular calcium mobilization ([@bibr1-0748730420923164]) showed a broader sensitivity to violet and green wavelengths than the Circadian Potency spectral sensitivity. Melanopsin, however, is tristable ([@bibr16-0748730420923164]), with each state having a different spectral sensitivity curve ([@bibr9-0748730420923164]), so this may account in part for the sustained narrow circadian spectral sensitivity we observed in light-adapted subjects.

There are differences in the method we used to determine circadian spectral sensitivity under light-adapted conditions as compared with the classic photobiology methods used in the dark-adapted state, where the dose-response curves have been used to derive circadian spectral sensitivities. Rather than fixing the response using the half-maximal effective dose (EC~50~), we fixed the input using approximately photon-matched lights. Most photobiological modeling of cones, rods, and ipRGCs is based on the dark-adapted retina and may not be directly applicable, so we have taken an empirical systems approach to derive the overall circadian sensitivity of the human circadian timing system in the light-adapted retina using total overnight melatonin as an output function, which is a well-validated circadian disruption and health risk biomarker.

With mounting evidence that artificial light sources can disrupt circadian rhythms and lead to myriad negative health outcomes, there is a dire need for biologically healthy light sources ([@bibr41-0748730420923164]). There are several problems with using the previously reported circadian spectral sensitivity curve from short exposures of dark-adapted subjects to monochromatic light to spectrally engineer healthy white light sources for day and night applications. First, the previously reported circadian spectral sensitivity from dark-adapted subjects spans a broad band of violet, blue, and green wavelengths (400-560 nm), and when all of these wavelengths are removed from the polychromatic 380- to 780-nm white light spectrum, the result is an unattractive yellow-orange light not suitable for most human uses. Second, the experimentally determined spectral sensitivity curves, and the circadian calculators derived from them, CS ([@bibr32-0748730420923164]), melanopic irradiance ([@bibr5-0748730420923164]) and EML ([@bibr19-0748730420923164]), are significantly inconsistent, leading to confusion in the lighting engineering and design communities ([@bibr6-0748730420923164]). Third, the sizeable recent gains in energy efficiency of lighting (from 5-10 lumens/watt of incandescents to the 100-200 lumens/watt efficacy of blue pump GaN-based LED dies) are currently not feasible to attain when this broad band of violet, blue, and green spectral wavelengths is removed to spectrally engineer nocturnal lighting, because the most energy-efficient dies are violet or blue. Fourth, there has previously been a lack of empirical circadian spectral sensitivity data derived from humans living and working in electrically illuminated workplace environments under normal intensities of polychromatic white light.

The steady-state Circadian Potency spectral sensitivity curve reported here should provide better clarity for defining the optimal design specifications required by circadian lighting. We recognize the precise shape of the Circadian Potency spectral sensitivity curve may be modified by interindividual differences such as ethnicity, age, and sex. A wide range of polynomial and other functions could potentially be used to define the steady-state Circadian Potency curve. However, the *R*^2^ coefficient of determination of 0.991 derived using the optimized Gaussian functions for short and long wavelengths and the peak sensitivity wavelength provides a sufficiently precise curve fit to describe the optimum Circadian Potency spectral sensitivity curve.

In comparison, the overnight 12-h melatonin AUC values under the 6 LED light sources are not explained by corneal light intensity metrics including total visible irradiance (*R*^2^ = 0.014), total photon irradiance (*R*^2^ = 0.028), or photopic lux (*R*^2^ = 0.097). We recognize that the range of irradiance, photon irradiance, and photopic illuminance (lux) values that could be examined with these data was limited, but the variation represents typical photometric ranges of lighting in the workplace.

Our findings from the overnight melatonin AUC suppression data under the 6 LED light sources (A-F) could not be adequately explained by the previously proposed circadian melanopic calculators, melanopic irradiance ([@bibr5-0748730420923164]); EML ([@bibr19-0748730420923164]), which had an *R*^2^ = 0.690; and CS ([@bibr32-0748730420923164]), which had a *R*^2^ = 0.001, which were primarily derived using data from short (≤90 min) monochromatic light exposures. This conclusion is supported by recent studies showing that the CS calculator accurately predicts the response to the first hour of light after a dark-adapted state but is less effective at predicting the responses to longer light exposures of 2 to 3 h ([@bibr24-0748730420923164]).

Normally the eyes of humans are fully dark adapted during the nocturnal hours of sleep in a dark room, and the first light exposure occurs with dawn or when the bedroom electric lights are switched on in the morning. Since the M-cone mediated extrinsic green and the S-cone mediated extrinsic violet, and inputs to the ipRGCs would be largely dissipated by the time an individual reaches their workplace (\>2 h after first morning exposure to light), we propose that our steady-state predominantly blue Circadian Potency spectral sensitivity be used for designing workplace LED lighting, whereas the initial circadian spectral sensitivity to light described by the CS, CIE, and EML calculators may be more applicable to the design of morning lighting in the home environment.

The definition of the steady-state Circadian Potency spectral sensitivity curve makes it feasible to design and build blue-rich white LED chips to optimize Circadian Potency during daytime hours and blue-depleted white LED chips to minimize Circadian Potency from sunset to sunrise. Because the steady-state Circadian Potency spectral sensitivity is narrower than the previously reported circadian spectral sensitivity curves for dark-adapted conditions, it permits the use of dies and phosphors that emit violet and green (plus yellow and red) wavelengths at night to produce attractive and energy-efficient white electric light, which minimizes circadian disruption.

When we examined the response to a fluorescent light source under the same experimental protocol, the melatonin AUC was suppressed to 37 ± 13.4 h∙pg/mL, which fell approximately midway in the 11.2- and 64.3-h∙pg/mL range of responses to the 6 LED light sources ([Fig. 1B](#fig1-0748730420923164){ref-type="fig"}). However, because the fluorescent light source was calculated to have a CPPR value of 0.276 using our LED-derived Circadian Potency function and an expected melatonin AUC of 28 h∙pg/mL, the Circadian Potency curve somewhat overestimated the melatonin-suppressive effects of this fluorescent light source, although it fell within 1 SEM of the measured value. It would require testing multiple fluorescent lights with different spectral power distributions to determine whether this is a general effect of fluorescent lights, but based on this result, we conclude that until such testing is done, the Circadian Potency function should be applied only to LED lights.

One particularly interesting feature of the Circadian Potency spectral sensitivity curve is the relative insensitivity to spectral wavelengths less than 420 nm. This permits the incorporation of 2 important features into nocturnal circadian lighting. First, violet LED dies with peak wavelengths of 410 to 420 nm can be used to replace the typical \~450-nm blue peak emissions of conventional LEDs to spectrally engineer colorimetrically balanced attractive white-colored light. Second, short-wavelength light is known to have alerting-, performance-, and mood-enhancing properties ([@bibr30-0748730420923164]; [@bibr39-0748730420923164]), leading to the proposal that blue-rich light should be used at night to reduce human error, but this has the unfortunate consequence that it could significantly increase the risk of circadian disruption and health disorders. However, the alerting effect of short-wavelength light can be retained in lights spectrally engineered to remove circadian-disruptive blue wavelengths by replacing them with \~420-nm violet wavelengths, especially since there is evidence that the alerting effects of 420-nm violet light are even greater than 440-nm or 470-nm blue light ([@bibr33-0748730420923164]).

Another application of the Circadian Potency spectral sensitivity curve is to phase shift the human circadian system to treat circadian sleep disorders or aid in the adjustment to work schedules or travel across time zones. Phase-response curves describe how circadian entrainment is achieved through the Circadian Potency wavelengths, alternatively phase advancing or phase delaying the circadian system depending on the circadian phase when high CPPR light is detected by the ipRGCs. The [@bibr34-0748730420923164] type 1 phase-response curve for monochromatic blue 480-nm light serves as the closest available approximation to the likely Circadian Potency phase-response curve. Using the Circadian Potency function makes it possible to spectrally engineer efficient white lights suitable for normal visual acuity while achieving the phase-resetting goal.

Why might evolutionary selection result in such a narrow band of blue wavelengths defined by the Circadian Potency spectral sensitivity curve being used to communicate the environmental day-night signal? We suggest it may be because life forms have been exposed to steady-state blue wavelengths during the day ever since the origin of life deep in the primitive oceans. Below a depth of 200 m, all other visible spectral wavelengths except for \~475-nm light are absorbed by seawater ([@bibr7-0748730420923164]). From single-cell marine organisms such as Gonyaulax ([@bibr14-0748730420923164]) to humans, the fundamental apparatus consisting of (1) blue photoreceptors maximally sensitivity at \~475 nm, (2) circadian clocks, and (3) melatonin release as the internal temporal signal has been conserved for billions of years to equip life for successful predictive adaptation to a rotating planet ([@bibr21-0748730420923164]).
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